Status:
NOT_YET_RECRUITING
Chronic Intervention With Sulforaphane-Smart® in Overweight and Obese Adults
Lead Sponsor:
Mª Jesús Periago
Collaborating Sponsors:
Ingredalia Company
Spanish National Research Council (CEBAS-CSIC)
Conditions:
Obesity and Overweight
Eligibility:
All Genders
20-45 years
Phase:
EARLY_PHASE1
Brief Summary
The Sulforaphane-Smart® formula is a pill, patented by the company INGREDALIA, prepared with broccoli by-products which have been concentrated and enriched in glucosinolates/isothiocyanates (GLS/ITCs)...
Detailed Description
Sulforaphan-Smart® is formula patented by the company INGREDALA (patented by INGREDALIA: EP3123874B1). This clinical trial will provide information about the beneficial effects of the consumption of S...
Eligibility Criteria
Inclusion
- BMI: overweight and obese (BMI 25-34,9 Kg/m2)
- No digestive or intestinal diseases
- Age between 20 and 45 years old
- Not having antibiotics during the previous three months
- Not having pharmacological treatment
- Not being smokers
- Not following restrictive diets (vegetarian/vegan diet) or nutritional supplement
Exclusion
- BMI: low and normal weight
- Age different from that required
- Digestive or intestinal diseases
- Having antibiotics during the previous three months
- Having pharmacological treatments
- Following restrictive diets (vegetarian/vegan diet) or nutritional supplement
- Smoker
Key Trial Info
Start Date :
July 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06964659
Start Date
July 1 2025
End Date
December 1 2026
Last Update
May 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Edificio Pleyades-Vitalys 5ª y 6ª planta, Campus Universitario, Espinardo
Murcia, Spain, Spain, 30100